✦ LIBER ✦

Uptake of 2-NBDG as a method to monitor therapy response in breast cancer cell lines

✍ Scribed by Stacy R. Millon; Julie H. Ostrander; J. Quincy Brown; Anita Raheja; Victoria L. Seewaldt; Nirmala Ramanujam

Publisher: Springer US
Year: 2010
Tongue: English
Weight: 471 KB
Volume: 126
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-010-0884-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Molecular profiling and predictive value

Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies

✍ Mitra Tewes; Bahriye Aktas; Anja Welt; Siemke Mueller; Siegfried Hauch; Rainer K 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 377 KB

Identification of a functional estrogen-

Identification of a functional estrogen-responsive enhancer element in the promoter 2 of PRDM2 gene in breast cancer cell lines

✍ Ciro Abbondanza; Caterina De Rosa; Andrea D'Arcangelo; Marianna Pacifico; Clorin 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 723 KB

## Abstract The __retinoblastoma protein‐interacting zinc‐finger__ (__RIZ__) gene, also known as __PRDM2__, encodes two protein products, RIZ1 and RIZ2, differing for the presence of a 202 aa domain, called PR domain, at the N‐terminus of the RIZ1 molecule. While the histone H3 K9 methyltransferase

PET-based estradiol challenge as a predi

PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer

✍ Farrokh Dehdashti; Joanne E. Mortimer; Kathryn Trinkaus; Michael J. Naughton; Ma 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 221 KB

Monitoring response to therapy in cancer

Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-d-glucose and positron emission tomography: an overview of different analytical methods

✍ C. J. Hoekstra; I. Paglianiti; O. S. Hoekstra; E. F. Smit; P. E. Postmus; G. J. 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 72 KB

The combination of letrozole and trastuz

The combination of letrozole and trastuzumab as first or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancers

✍ P. Kelly Marcom; Claudine Isaacs; Lyndsay Harris; Zee Wang Wong; Aruna Kommarred 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 144 KB

Immunocytochemical localization of BCL-2

Immunocytochemical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy

✍ Julia M. W. Gee; John F. R. Robertson; Ian O. Ellis; Peter Willsher; Richard A. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 824 KB

The protein product of the bcl-2 gene is thought to be involved in inhibition of apoptosis; it may therefore be important in the modulation of hormonal/anti-hormonal responsiveness exhibited by tumours. This study immunocytochemically investigates (i) relationships between bcl-2 protein expression i